<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">31923552</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>04</Month>
        <Day>27</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>04</Month>
        <Day>27</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1090-2139</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>87</Volume>
            <PubDate>
              <Year>2020</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>Brain, behavior, and immunity</Title>
          <ISOAbbreviation>Brain Behav Immun</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Locus coeruleus neurons are most sensitive to chronic neuroinflammation-induced neurodegeneration.</ArticleTitle>
        <Pagination>
          <StartPage>359</StartPage>
          <EndPage>368</EndPage>
          <MedlinePgn>359-368</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbi.2020.01.003</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0889-1591(19)31354-6</ELocationID>
        <Abstract>
          <AbstractText>Parkinson's disease (PD) develops over decades through spatiotemporal stages that ascend from the brainstem to the forebrain. The mechanism behind this caudo-rostral neurodegeneration remains largely undefined. In unraveling this phenomenon, we recently developed a lipopolysaccharide (LPS)-elicited chronic neuroinflammatory mouse model that displays sequential losses of neurons in brainstem, substantia nigra, hippocampus and cortex. In this study, we aimed to investigate the mechanisms of caudo-rostral neurodegeneration and focused our efforts on the earliest neurodegeneration of vulnerable noradrenergic locus coeruleus (NE-LC) neurons in the brainstem. We found that compared with neurons in other brain regions, NE-LC neurons in untreated mice displayed high levels of mitochondrial oxidative stress that was severely exacerbated in the presence of LPS-elicited chronic neuroinflammation. In agreement, NE-LC neurons in LPS-treated mice displayed early reduction of complex IV expression and mitochondrial swelling and loss of cristae. Mechanistically, the activation of the superoxide-generating enzyme NADPH oxidase (NOX2) on NE-LC neurons was essential for their heightened vulnerability during chronic neuroinflammation. LPS induced early and high expressions of NOX2 in NE-LC neurons. Genetic or pharmacological inactivation of NOX2 markedly reduced mitochondrial oxidative stress and dysfunction in LPS-treated mice. Furthermore, inhibition of NOX2 significantly ameliorated LPS-induced NE-LC neurodegeneration. More importantly, post-treatment with NOX2 inhibitor diphenyleneiodonium when NE-LC neurodegeneration had already begun, still showed high efficacy in protecting NE-LC neurons from degeneration in LPS-treated mice. This study strongly supports that chronic neuroinflammation and NOX2 expression among vulnerable neuronal populations contribute to caudo-rostral degeneration in PD.</AbstractText>
          <CopyrightInformation>Copyright © 2020 Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Qingshan</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>School of Public Health, Dalian Medical University, Dalian, Liaoning, China; National-Local Joint Engineering Research Center for Drug-Research and Development (R &amp; D) of Neurodegenerative Diseases, Dalian Medical University, Dalian, Liaoning, China. Electronic address: wangq4@126.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oyarzabal</LastName>
            <ForeName>Esteban A</ForeName>
            <Initials>EA</Initials>
            <AffiliationInfo>
              <Affiliation>Neurobiology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Song</LastName>
            <ForeName>Sheng</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Neurobiology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wilson</LastName>
            <ForeName>Belinda</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Neurobiology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Santos</LastName>
            <ForeName>Janine H</ForeName>
            <Initials>JH</Initials>
            <AffiliationInfo>
              <Affiliation>Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hong</LastName>
            <ForeName>Jau-Shyong</ForeName>
            <Initials>JS</Initials>
            <AffiliationInfo>
              <Affiliation>Neurobiology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>Z01 ES090082</GrantID>
            <Acronym>ImNIH</Acronym>
            <Agency>Intramural NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>01</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Brain Behav Immun</MedlineTA>
        <NlmUniqueID>8800478</NlmUniqueID>
        <ISSNLinking>0889-1591</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D059331" MajorTopicYN="Y">Adrenergic Neurons</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059290" MajorTopicYN="N">Dopaminergic Neurons</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008125" MajorTopicYN="Y">Locus Coeruleus</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Mitochondria</Keyword>
        <Keyword MajorTopicYN="Y">Neuroinflammation</Keyword>
        <Keyword MajorTopicYN="Y">Noradrenergic locus coeruleus neuron</Keyword>
        <Keyword MajorTopicYN="Y">Oxidative stress</Keyword>
        <Keyword MajorTopicYN="Y">Parkinson’s disease</Keyword>
        <Keyword MajorTopicYN="Y">Vulnerability</Keyword>
      </KeywordList>
      <CoiStatement>COMPETING FINANCIAL INTERESTS. The authors declare no competing financial interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31923552</ArticleId>
        <ArticleId IdType="mid">NIHMS1561439</ArticleId>
        <ArticleId IdType="pmc">PMC7316605</ArticleId>
        <ArticleId IdType="doi">10.1016/j.bbi.2020.01.003</ArticleId>
        <ArticleId IdType="pii">S0889-1591(19)31354-6</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Aiello GL, Bach-y-Rita P, 2000. 
The cost of an action potential. J Neurosci Methods
103, 145–149.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11084206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alibhai J, Blanco RA, Barria MA, Piccardo P, Caughey B, Perry VH, Freeman TC, Manson JC, 2016. 
Distribution of Misfolded Prion Protein Seeding Activity Alone Does Not Predict Regions of Neurodegeneration. PLoS Biol
14, e1002579.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5120774</ArticleId>
            <ArticleId IdType="pubmed">27880767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berridge CW, Waterhouse BD, 2003. 
The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev
42, 33–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12668290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Block ML, Zecca L, Hong JS, 2007. 
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci
8, 57–69.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17180163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E, 2003. 
Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging
24, 197–211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12498954</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carter C, 2011. 
Alzheimer’s Disease: APP, Gamma Secretase, APOE, CLU, CR1, PICALM, ABCA7, BIN1, CD2AP, CD33, EPHA1, and MS4A2, and Their Relationships with Herpes Simplex, C. Pneumoniae, Other Suspect Pathogens, and the Immune System. Int J Alzheimers Dis
2011, 501862.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3255168</ArticleId>
            <ArticleId IdType="pubmed">22254144</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chinta SJ, Andersen JK, 2011. 
Nitrosylation and nitration of mitochondrial complex I in Parkinson’s disease. Free Radic Res
45, 53–58.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20815786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Costa AD, Quinlan CL, Andrukhiv A, West IC, Jaburek M, Garlid KD, 2006. 
The direct physiological effects of mitoK(ATP) opening on heart mitochondria. Am J Physiol Heart Circ Physiol
290, H406–415.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16143645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dikalov SI, Nazarewicz RR, Bikineyeva A, Hilenski L, Lassegue B, Griendling KK, Harrison DG, Dikalova AE, 2014. 
Nox2-induced production of mitochondrial superoxide in angiotensin II-mediated endothelial oxidative stress and hypertension. Antioxid Redox Signal
20, 281–294.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3887459</ArticleId>
            <ArticleId IdType="pubmed">24053613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doughan AK, Harrison DG, Dikalov SI, 2008. 
Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res
102, 488–496.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18096818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El-Ani D, Zimlichman R, 2003. 
TNFalpha stimulated ATP-sensitive potassium channels and attenuated deoxyglucose and Ca uptake of H9c2 cardiomyocytes. Ann N Y Acad Sci
1010, 716–720.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15033816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fukui H, Moraes CT, 2008. 
The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis?
Trends Neurosci
31, 251–256.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2731695</ArticleId>
            <ArticleId IdType="pubmed">18403030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao HM, Zhou H, Hong JS, 2012. 
NADPH oxidases: novel therapeutic targets for neurodegenerative diseases. Trends Pharmacol Sci
33, 295–303.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3477578</ArticleId>
            <ArticleId IdType="pubmed">22503440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gispert S, Del Turco D, Garrett L, Chen A, Bernard DJ, Hamm-Clement J, Korf HW, Deller T, Braak H, Auburger G, Nussbaum RL, 2003. 
Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation. Mol Cell Neurosci
24, 419–429.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14572463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Helwig M, Klinkenberg M, Rusconi R, Musgrove RE, Majbour NK, El-Agnaf OM, Ulusoy A, Di Monte DA, 2016. 
Brain propagation of transduced alpha-synuclein involves non-fibrillar protein species and is enhanced in alpha-synuclein null mice. Brain
139, 856–870.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26719384</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Bjorklund T, Wang ZY, Roybon L, Melki R, Li JY, 2014. 
Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol
128, 805–820.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25296989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hunter RL, Cheng B, Choi DY, Liu M, Liu S, Cass WA, Bing G, 2009. 
Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 mice. J Neurosci Res
87, 1913–1921.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2692550</ArticleId>
            <ArticleId IdType="pubmed">19224579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Infanger DW, Sharma RV, Davisson RL, 2006. 
NADPH oxidases of the brain: distribution, regulation, and function. Antioxid Redox Signal
8, 1583–1596.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16987013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lohr JB, Jeste DV, 1988. 
Locus ceruleus morphometry in aging and schizophrenia. Acta Psychiatr Scand
77, 689–697.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3044009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luk KC, Kehm V, Carroll J, Zhang B, O’Brien P, Trojanowski JQ, Lee VM, 2012. 
Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science
338, 949–953.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3552321</ArticleId>
            <ArticleId IdType="pubmed">23161999</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin LJ, Pan Y, Price AC, Sterling W, Copeland NG, Jenkins NA, Price DL, Lee MK, 2006. 
Parkinson’s disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci
26, 41–50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6381830</ArticleId>
            <ArticleId IdType="pubmed">16399671</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marty C, Kozasa T, Quinn MT, Ye RD, 2006. 
Activation state-dependent interaction between Galphai and p67phox. Mol Cell Biol
26, 5190–5200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1489143</ArticleId>
            <ArticleId IdType="pubmed">16782902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mason DM, Nouraei N, Pant DB, Miner KM, Hutchison DF, Luk KC, Stolz JF, Leak RK, 2016. 
Transmission of alpha-synucleinopathy from olfactory structures deep into the temporal lobe. Mol Neurodegener
11, 49.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4929736</ArticleId>
            <ArticleId IdType="pubmed">27363576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mattson MP, 2000. 
Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol
1, 120–129.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11253364</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McKee AC, Stern RA, Nowinski CJ, Stein TD, Alvarez VE, Daneshvar DH, Lee HS, Wojtowicz SM, Hall G, Baugh CM, Riley DO, Kubilus CA, Cormier KA, Jacobs MA, Martin BR, Abraham CR, Ikezu T, Reichard RR, Wolozin BL, Budson AE, Goldstein LE, Kowall NW, Cantu RC, 2013. 
The spectrum of disease in chronic traumatic encephalopathy. Brain
136, 43–64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3624697</ArticleId>
            <ArticleId IdType="pubmed">23208308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakamura T, Lipton SA, 2011. 
Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases. Cell Death Differ
18, 1478–1486.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3178424</ArticleId>
            <ArticleId IdType="pubmed">21597461</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neumann H, Daly MJ, 2013. 
Variant TREM2 as risk factor for Alzheimer’s disease. N Engl J Med
368, 182–184.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23151315</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Osterberg VR, Spinelli KJ, Weston LJ, Luk KC, Woltjer RL, Unni VK, 2015. 
Progressive aggregation of alpha-synuclein and selective degeneration of lewy inclusion-bearing neurons in a mouse model of parkinsonism. Cell Rep
10, 1252–1260.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4351119</ArticleId>
            <ArticleId IdType="pubmed">25732816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ouchi Y, Yagi S, Yokokura M, Sakamoto M, 2009. 
Neuroinflammation in the living brain of Parkinson’s disease. Parkinsonism Relat Disord
15
Suppl 3, S200–204.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20082990</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK, 1990. 
Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci
95, 119–139.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2157823</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT, 2007. 
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia
55, 453–462.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2871685</ArticleId>
            <ArticleId IdType="pubmed">17203472</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rietdijk CD, Perez-Pardo P, Garssen J, van Wezel RJ, Kraneveld AD, 2017. 
Exploring Braak’s Hypothesis of Parkinson’s Disease. Front Neurol
8, 37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5304413</ArticleId>
            <ArticleId IdType="pubmed">28243222</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rudow G, O’Brien R, Savonenko AV, Resnick SM, Zonderman AB, Pletnikova O, Marsh L, Dawson TM, Crain BJ, West MJ, Troncoso JC, 2008. 
Morphometry of the human substantia nigra in ageing and Parkinson’s disease. Acta Neuropathol
115, 461–470.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2431149</ArticleId>
            <ArticleId IdType="pubmed">18297291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sacino AN, Brooks M, Thomas MA, McKinney AB, McGarvey NH, Rutherford NJ, Ceballos-Diaz C, Robertson J, Golde TE, Giasson BI, 2014. 
Amyloidogenic alpha-synuclein seeds do not invariably induce rapid, widespread pathology in mice. Acta Neuropathol
127, 645–665.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4869357</ArticleId>
            <ArticleId IdType="pubmed">24659240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanchez-Padilla J, Guzman JN, Ilijic E, Kondapalli J, Galtieri DJ, Yang B, Schieber S, Oertel W, Wokosin D, Schumacker PT, Surmeier DJ, 2014. 
Mitochondrial oxidant stress in locus coeruleus is regulated by activity and nitric oxide synthase. Nat Neurosci
17, 832–840.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4131291</ArticleId>
            <ArticleId IdType="pubmed">24816140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sara SJ, 2009. 
The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci
10, 211–223.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19190638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schapira AH, Gegg M, 2011. 
Mitochondrial contribution to Parkinson’s disease pathogenesis. Parkinsons Dis
2011, 159160.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3109314</ArticleId>
            <ArticleId IdType="pubmed">21687805</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schulz E, Wenzel P, Munzel T, Daiber A, 2014. 
Mitochondrial redox signaling: Interaction of mitochondrial reactive oxygen species with other sources of oxidative stress. Antioxid Redox Signal
20, 308–324.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3887453</ArticleId>
            <ArticleId IdType="pubmed">22657349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song S, Jiang L, Oyarzabal EA, Wilson B, Li Z, Shih YI, Wang Q, Hong JS, 2019a. 
Loss of Brain Norepinephrine Elicits Neuroinflammation-Mediated Oxidative Injury and Selective Caudo-Rostral Neurodegeneration. Mol Neurobiol
56, 2653–2669.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6348128</ArticleId>
            <ArticleId IdType="pubmed">30051353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song S, Wang Q, Jiang L, Oyarzabal E, Riddick NV, Wilson B, Moy SS, Shih YI, Hong JS, 2019b. 
Noradrenergic dysfunction accelerates LPS-elicited inflammation-related ascending sequential neurodegeneration and deficits in non-motor/motor functions. Brain Behav Immun
81, 374–387.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6754798</ArticleId>
            <ArticleId IdType="pubmed">31247288</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stark AK, Pakkenberg B, 2004. 
Histological changes of the dopaminergic nigrostriatal system in aging. Cell Tissue Res
318, 81–92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15365813</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Szabo C, Ischiropoulos H, Radi R, 2007. 
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov
6, 662–680.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17667957</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vitkovic L, Konsman JP, Bockaert J, Dantzer R, Homburger V, Jacque C, 2000. 
Cytokine signals propagate through the brain. Mol Psychiatry
5, 604–615.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11126391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Q, Qian L, Chen SH, Chu CH, Wilson B, Oyarzabal E, Ali S, Robinson B, Rao D, Hong JS, 2015. 
Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson’s disease models. Brain
138, 1247–1262.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4407187</ArticleId>
            <ArticleId IdType="pubmed">25716193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Witte ME, Geurts JJ, de Vries HE, van der Valk P, van Horssen J, 2010. 
Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration?
Mitochondrion
10, 411–418.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20573557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zarow C, Lyness SA, Mortimer JA, Chui HC, 2003. 
Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol
60, 337–341.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12633144</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou R, Yazdi AS, Menu P, Tschopp J, 2011. 
A role for mitochondria in NLRP3 inflammasome activation. Nature
469, 221–225.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21124315</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
